Japan Takes Aim at Ballooning Drug Prices as Costs Strain Budget

When two of the world’s biggest pharmaceutical companies announced a tie-up in Japan, the country’s $78 billion drug industry took note.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.